NOV 14, 2019 9:00 AM PST

Drug testing in Regulatory Monitoring

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Director Washington Health Professional Services, Nursing Care Quality Assurance Commission, Washington State Department of Health
    Biography
      Dr. Furman is the Director of Washington State Health Professional Services (WHPS). WHPS is the state approved Alternative to Discipline substance use monitoring program for the nursing professions. He has worked for the state of Washington for 40 years primarily in the areas of behavioral and occupational health. Educational background includes undergraduate and graduate degrees in nursing, doctorate in health administration, and certification as an occupational health nurse-specialist. Dr. Furman has been involved in the promotion of healthcare safety for many years serving as the president of the Pacific Northwest Chapter of the Association of Occupational Health Professionals (AOHP), vice-president of the Puget Sound Chapter of the Association of Professionals in Infection Control, and vice-president of the Washington Healthcare Safety Council (WHCSC). In addition he has completed two appointments on the National Organization of Alternative Programs (NOAP) Executive Committee, and currently serves on the Journal of Occupational Health Professionals (AOHP) editorial committee. Prior to coming to WHPS Dr. Furman worked with the Department of Labor & Industries Division of Occupational Safety and Health (DOSH). Where he helped develop nationally recognized programs on pesticide exposure monitoring, and outdoor heat exposure. Just prior to leaving the DOSH program he acted as the primary author of the nation's first Healthcare Hazardous Drug Exposure regulation.

    Abstract

    Random drug testing is used as a preventive and detection tool for drug or alcohol use, and medication compliance in the monitoring of regulatory and treatment compliance monitoring. Urine screening is generally viewed as the preferred method for assessing substance use and may be supplemented with hair, blood or nail testing to assess for drug use over long periods. A positive drug test does not provide information about the levels of impairment but only that a drug or substance was used within the detection period and requires immediate attention. Selection of competent laboratories and Medical Review Officer support is essential to ensure accurate drug testing and evaluation.


    Show Resources
    You May Also Like
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    Loading Comments...
    Show Resources
    Attendees
    • See more